{"database": "open_comments", "table": "documents", "rows": [["FDA-2007-D-0369-2670", "FDA", "FDA-2007-D-0369", "PSG_021977 - Draft Guidance on Lisdexamfetamine Dimesylate", "Other", "Guidance", "2026-08-24", 2026, 8, "2026-08-24", "2026-10-23", "2026-10-24 03:59:59", 0, "2026-08-24 20:10:41", null, 1, 0, "09000064b94706d0"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "comment_end_datetime", "perpetual_docket", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2007-D-0369-2670"], "units": {}, "query_ms": 0.30035502277314663, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}